about
Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytesAre some idiopathic epilepsies disorders of ion channels?: A working hypothesis.Genetic abnormalities underlying familial epilepsy syndromes.Genetics of epilepsy: current status and perspectives.Genetic identifiers of epilepsy.The genetics of febrile seizures and related epilepsy syndromes.The development of agoraphobia is associated with the symptoms and location of a patient's first panic attackDefective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor.Hyperpolarization-activated cyclic nucleotide gated channels: a potential molecular link between epileptic seizures and Aβ generation in Alzheimer's diseaseA de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions.ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation.Improved accuracy of diagnosis of lumbar intra and/or extra-foraminal stenosis by use of three-dimensional MR imaging: comparison with conventional MR imaging.Pharmacological discrimination of protein kinase associated exocytosis mechanisms between dopamine and 3,4-dihydroxyphenylalanine in rat striatum using in vivo microdialysis.Determination of exocytosis mechanisms of DOPA in rat striatum using in vivo microdialysis.Effects of valproate on neurotransmission associated with ryanodine receptors.Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epilepticus.Dysfunction of M-channel enhances propagation of neuronal excitability in rat hippocampus monitored by multielectrode dish and microdialysis systems.Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies.Interaction between carbamazepine, zonisamide and voltage-sensitive Ca2+ channel on acetylcholine release in rat frontal cortex.Both 3,4-dihydroxyphenylalanine and dopamine releases are regulated by Ca2+-induced Ca2+ releasing system in rat striatum.Protein kinase associated with gating and closing transmission mechanisms in temporoammonic pathway.Relationship between the prefrontal function during a cognitive task and the severity of the symptoms in patients with panic disorder: a multi-channel NIRS study.Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.Asymmetry of prefrontal cortex activities and catechol-O-methyltransferase Val158Met genotype in patients with panic disorder during a verbal fluency task: near-infrared spectroscopy study.Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin.Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype.Biphasic actions of topiramate on monoamine exocytosis associated with both soluble N-ethylmaleimide-sensitive factor attachment protein receptors and Ca(2+)-induced Ca(2+)-releasing systems.Zonisamide at clinically relevant concentrations inhibits field EPSP but not presynaptic fiber volley in rat frontal cortex.The Association of BDNF Val66Met Polymorphism With Trait Anxiety in Panic Disorder.Incidence and Risk Factors of Postoperative Delirium following Pancreatic Surgery: Does the Administration of TJ-54 Reduce the Incidence of Delirium.Spontaneous epileptic seizures in transgenic rats harboring a human ADNFLE missense mutation in the β2-subunit of the nicotinic acetylcholine receptor.Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1.Mutation screening of AP3M2 in Japanese epilepsy patients.An event-related fNIRS investigation of Japanese word order.Effects of carbamazepine on hippocampal serotonergic system.Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release.Levetiracetam inhibits neurotransmitter release associated with CICR.Prognosis and clinical features of intractable epilepsy: a prospective study.Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex.Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis.
P50
Q24606088-F8942F36-7AAB-4AD1-947A-C7937191F19DQ34016353-CB482E22-7B45-4352-8460-D565B44BAA0BQ34641436-A95FB81E-0AB5-4B10-9E35-D079A62B6D6CQ34804508-D80996FF-509C-490F-8C33-70A11E77313DQ34970015-4DC32D94-5DDB-416E-9281-CD952B4F476FQ35173040-E0AA1CF8-7015-4779-A746-81D52CA9086CQ35951051-B7BD1A16-AC68-4064-9F06-FCEFD6A7D3C9Q36322693-5939A192-0DE8-48D0-B7A1-3BBD565A69B1Q36473977-4A29F3E8-0842-4292-9A4C-BD037BC4A741Q39959276-6BE4CF83-628F-432A-B0BA-5952DE5127B3Q41268825-50706132-6A5B-4F94-84B3-2C9127C9D1AAQ41710439-6B0F5FA5-C12D-42F7-9B3F-2F5584815DF8Q42462432-1CD5EF7B-D3AC-4943-B657-5726F9860D39Q42466653-B3BAD94A-3CAD-499A-A911-9AAED6210903Q42476864-7979E466-E7D9-4A48-82F6-9EA39E3374F6Q42480460-76A0103D-55B4-4F44-82DE-4D09353CA252Q42494967-38FD790F-5903-49DA-9B42-18692E2BE2A0Q43059162-CBE8127F-E496-46AC-A408-B03BEA65A1B1Q43955551-85CB327B-9FA7-41B6-BF4F-8AAA4BBEE24CQ44906379-0183DAC9-1A0B-490B-83B5-ADE2B0FAF318Q45068195-0A21FDF0-40D9-4A87-9AD5-B870CF6893EEQ45338959-A8BAE1F3-B35B-4A60-9D29-D076196AA45DQ45989675-9BBCE527-15AA-42FD-8E30-1A84C7D087DAQ46018208-D9E25A4F-3FA9-405E-95B7-7180DD411C40Q46096835-EE80DBD1-B32A-4200-9941-1F926CEEC3F8Q46237563-B71EB050-5905-4799-8F5C-A874A73CF04CQ46551152-C8B2C8E9-7910-410B-A952-C39F2135B99DQ46724063-EEAD31DC-8B7D-4CB9-8EE2-F71E6BA16343Q47690417-93788832-A34C-4DC6-A8B9-EDF07451055DQ47766016-F22B74B1-47BE-4A6E-9C7B-A3C783FB0E8BQ48120368-321C19A2-BF07-4977-8FA4-B63279D90AC2Q48160576-EE93964F-D5F8-42F9-A071-AB451F054D23Q48276265-96C23A73-D0BD-4FAC-A3C2-ADB9115E9F43Q48368238-08EF10A6-C29B-4342-AC7C-62137D144E52Q48403480-2805AB0A-030C-4E6D-BC08-EBC37F0AC569Q48411571-4C345A53-7D81-457D-A858-4BC7CD8FA464Q48579589-A23717EC-85DD-48A7-A216-02E5B957C8D3Q48641625-0948AB1C-1B64-478A-BD9F-C032894F5230Q48698111-3DB0BE19-5E8F-4A6D-90CF-40602ED6054DQ48795778-14098AA7-60EA-44B0-B921-19369B00FFE1
P50
description
researcher ORCID ID = 0000-0002-9025-2548
@en
wetenschapper
@nl
name
Motohiro Okada
@ast
Motohiro Okada
@en
Motohiro Okada
@es
Motohiro Okada
@nl
type
label
Motohiro Okada
@ast
Motohiro Okada
@en
Motohiro Okada
@es
Motohiro Okada
@nl
prefLabel
Motohiro Okada
@ast
Motohiro Okada
@en
Motohiro Okada
@es
Motohiro Okada
@nl
P106
P108
P31
P496
0000-0002-9025-2548